TrialCard exec describes how her experience in biotech consulting led to her current position.
In an interview with Pharma Commerce Editor, Nicholas Saraceno, Diana Villanova, VP, patient support services strategy, TrialCard, speaks on her past experience in biotech consulting.
The Biosimilars Landscape Through the Eyes of an Economist
February 21st 2025James D. Chambers, PhD, MPharm, MSc, professor of medicine at the Tufts Medical Center Institute for Clinical Research and Health Policy Studies, dives into why biosimilars contribute to a reduction in cost and increase in patient access, while highlighting challenges to adoption.